Advertisement

Small Lymphocytic Lymphoma (SLL) | Tumor

CURE’s small lymphocytic lymphoma (SLL) page is a go-to resource for oncology news and updates in the world of SLL. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in small lymphocytic lymphoma (SLL).

BTK Inhibitors Offer a Revolutionary Treatment of Relapsed CLL/SLL

March 14th 2023

Bruton tyrosine kinase inhibitors have changed the space for treating patients with CLL or SLL, with more on the way to potentially address drug resistance.

Here We Go Again: Waiting for Results After Another Cancer Scare

February 15th 2023

I was optimistic about my lymphoma diagnosis and new treatment plan when a lump was found after I underwent a mammogram.

Brukinsa Offers Better Response and Less Toxicity for CLL and SLL Treatment, But a Cure Is Still Needed

January 30th 2023

Two experts explain what patients need to know about the recent approval of Brukinsa for patients with chronic lymphocytic leukemia and small lymphocytic leukemia.

My Oncologist Gave Me Hope

October 22nd 2022

After being diagnosed with lymphoma, I scheduled consultations with three oncologists, but only one provided me with the hope I needed.

FDA Approves Calquence for Leukemia and Lymphoma Subsets

November 21st 2019

In partnership with the Australian Therapeutic Goods Administration (TGA) and Health Canada, the Food and Drug Administration (FDA) has granted supplemental approval to Calquence (acalabrutinib) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

FDA Approves Venclexta-Gazyva Combo as Frontline Treatment for CLL/SLL

May 15th 2019

The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

2018 FDA Advancements in Small Lymphocytic Leukemia

November 29th 2018

Take a look at the FDA’s decisions for the treatment of SLL that happened this year.

Imbruvica Yields Favorable Safety Outcomes in Two Types of Lymphomas

November 12th 2018

Imbruvica (ibrutinib) is a safe treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), according to a pooled analysis of four clinical trials.

FDA Approves Copiktra for Two Types of Blood Cancer

September 25th 2018

The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma.

Advertisement
Advertisement